Published online Dec 28, 2015. doi: 10.3748/wjg.v21.i48.13524
Peer-review started: June 25, 2015
First decision: July 19, 2015
Revised: August 7, 2015
Accepted: October 12, 2015
Article in press: October 13, 2015
Published online: December 28, 2015
Processing time: 187 Days and 5.2 Hours
AIM: To evaluate the dynamic computed tomography (CT) findings of liver metastasis from hepatoid adenocarcinoma of the stomach (HAS) and compared them with hepatocellular carcinoma (HCC).
METHODS: Between January 2000 and January 2015, 8 patients with pathologically proven HAS and liver metastases were enrolled. Basic tumor status was evaluated for the primary tumor location and metastatic sites. The CT findings of the liver metastases were analyzed for tumor number and size, presence of tumor necrosis, hemorrhage, venous tumor thrombosis, and dynamic enhancing pattern.
RESULTS: The body and antrum were the most common site for primary HAS (n = 7), and observed metastatic sites included the liver (n = 8), lymph nodes (n = 7), peritoneum (n = 4), and lung (n = 2). Most of the liver metastases exhibited tumor necrosis regardless of tumor size. By contrast, tumor hemorrhage was observed only in liver lesions larger than 5 cm (n = 4). Three patterns of venous tumor thrombosis were identified: direct venous invasion by the primary HAS (n = 1), direct venous invasion by the liver metastases (n = 7), and isolated portal vein tumor thrombosis (n = 2). Dynamic CT revealed arterial hyperattenuation and late phase washout in all the liver metastases.
CONCLUSION: On dynamic CT, liver metastasis from HAS shared many imaging similarities with HCC. For liver nodules, the presence of isolated portal vein tumor thrombosis and a tendency for tumor necrosis are imaging clues that suggest the diagnosis of HAS.
Core tip: Hepatoid adenocarcinoma of the stomach (HAS) is a rare form of gastric cancer with clinicopathological presentation mimicking hepatocellular carcinoma (HCC). The high similarity between the two diseases makes the differential diagnosis challenging, especially when the primary tumor is unknown, and the liver nodules are the only initial finding. In the present study, identical dynamic enhancing pattern (arterial hyperattenuation and late phase washout) between liver metastasis from HAS and HCC was confirmed. Moreover, the presence of isolated portal vein tumor thrombosis and a tendency of tumor necrosis are the imaging clues that suggest the diagnosis of HAS rather than HCC.